"To place a man in a multi-stage rocket and project him into the controlling gravitational field of the moon where the passengers can make scientific observations, perhaps land alive, and then return to earth--all that constitutes a wild dream worthy of Jules Verne. I am bold enough to say that such a man-made voyage will never occur regardless of all future advances."
Lee deForest, American radio pioneer ; 1957
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7968692 | Elongase genes and uses thereof The subject invention relates to the identification of several genes involved in the elongation of polyunsaturated fatty acids (i.e., “elongases”) and to uses thereof. At least two of these genes are also involved in the elongation of monounsaturated fatty acids... | 06/28/2011 |
| 7891510 | Container closure assembly An assembly includes a container and a closure. The closure includes a tamper-indicating band having a plurality of sloping teeth. Each of the sloping teeth of the tamper-indicating band has an engagement surface that is engageable with one of the engagement surface... | 02/22/2011 |
| 7879796 | Amino acid composition for improving glucose tolerance Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impa... | 02/01/2011 |
| 7829126 | Infant formulas containing docosahexaenoic acid and lutein Disclosed are infant formulas and corresponding methods of using them to promote retinal health and vision development in infants. The formulas, which are free of egg phospholipids and comprise fat, protein, carbohydrate, vitamins, and minerals, including docosahexa... | 11/09/2010 |
| 7759507 | Lipid system and methods of use The present invention relates to a lipid system, and methods for using such a lipid system, containing specific relative ratios of omega-3, omega-6, and omega-9 fatty acids. The lipid system may be used independently or as a component of a nutritional product. A lip... | 07/20/2010 |
| 7723503 | Desaturase genes, enzymes encoded thereby, and uses thereof Disclosed are isolated polynucleotides encoding an omega-3 desaturase and a delta-12 desaturase, the enzymes encoded by the isolated polynucleotides, vectors containing the isolated polynucleotides, transgenic hosts that contain the isolated polynucleotides that exp... | 05/25/2010 |
| 7645470 | Iron-fortified, milk-based, flavored beverages with improved color Disclosed are flavored nutritional beverages comprising (A) fat; (B) milk protein representing from about 10% to 100% by weight of total protein; (C) carbohydrate comprising from about 75% to 100% by weight of at least one of (i) from about 0.1% to about 10% sucrose... | 01/12/2010 |
| 7601757 | Lipid system and methods of use The present invention relates to a lipid system, and methods for using such a lipid system, containing specific relative ratios of omega-3, omega-6, and omega-9 fatty acids. The lipid system may be used independently or as a component of a nutritional product. A lip... | 10/13/2009 |
| 7601705 | Polymer controlled induced viscosity fiber system and uses thereof The present invention relates generally to a method of blunting the postprandial glycemic response in a human by feeding an induced viscosity fiber system. The invention also relates to an induced viscosity fiber system and the liquid products that incorporate the i... | 10/13/2009 |
| 7601370 | Method for controlling body weight in estrogen-insufficient women Disclosed are methods of controlling body weight in estrogen-insufficient women by administering compositions comprising (A) those dried fruit solids that inherently comprise flavonoids, hydroxycinnamic acids, and a fiber component of which at least about 20% by wei... | 10/13/2009 |
| 7456270 | Δ6-desaturase genes and uses thereof The subject invention relates to the identification of genes involved in the desaturation of polyunsaturated fatty acids at carbon 6 (i.e., “Δ6-desaturase”). In particular, Δ6-desaturase may be utilized, for example, in the conversion of linoleic acid to γ-li... | 11/25/2008 |
| 7435431 | Method for controlling body weight in estrogen-insufficient women Disclosed are methods of controlling body weight in estrogen-insufficient women by administering compositions comprising (A) those dried fruit solids that inherently comprise flavonoids, hydroxycinnamic acids, and a fiber component of which at least about 20% by wei... | 10/14/2008 |
| 7423027 | Methods of using gamma cyclodextrin to control blood glucose and insulin secretion Disclosed are methods of producing a blunted postprandial glycemic response in an individual, and/or reducing postprandial insulin secretion, said methods comprising administering to the individual a nutritional or other product comprising gamma-cyclodextrin. Also d... | 09/09/2008 |
| 7422763 | Acid controlled induced viscosity fiber system and uses thereof The present invention relates generally to a method of blunting the postprandial glycemic response to a meal by feeding an acid controlled induced viscosity fiber system. The first component of the induced viscosity fiber system is anionic soluble fiber. The second ... | 09/09/2008 |
| 7393659 | Analytical method for the determination of infant formula protein digestibility in vitro A method for in vitro determination of the digestibility of proteins in a nutritional product. The method utilized gastric and intestinal enzymes that are standardized for in vitro digestion process that mimics the in vivo digestive process. Further, specificity in ... | 07/01/2008 |
| 7375205 | Elongase genes and uses thereof The subject invention relates to the identification of several genes involved in the elongation of polyunsaturated fatty acids (i.e., “elongases”) and to uses thereof. At least two of these genes are also involved in the elongation of monounsaturated fatty acids... | 05/20/2008 |
| 7368552 | Genes involved in polyketide synthase pathways and uses thereof The subject invention relates to isolated nucleic acid sequences or genes involved in polyketide synthase (PKS) biosynthetic pathways. In particular, such pathways are involved in the production of polyunsaturated fatty acids (PUFAs) such as, for example, Eicosapent... | 05/06/2008 |
| 7332178 | Stable nutritional powder containing ascorbyl palmitate Disclosed are nutritional powders, including lactose-free powders or other oxidatively sensitive nutritional powders, comprising at least about 400 ppm by weight of ascorbyl palmitate, preferably in combination with at least about 300 ppm by weight of cystine, cyste... | 02/19/2008 |
| 7323200 | Calcium fortified, soy based, infant nutritional formulas Disclosed are calcium fortified, soy-based, infant nutritional formulas, including powder, liquid, or concentrate embodiments comprising per 100 kcal of formula (A) lipid, preferably up to about 8.0 g, (B) carbohydrate, preferably from about 8.0 g to about 16.0 g, (... | 01/29/2008 |
| 7261911 | Aseptically packaged, extensively hydrolyzed, liquid nutritional formula and method for making it Disclosed are sterilized, aseptically packaged, liquid nutritional formulas, and corresponding methods of making the formulas, wherein the formulas comprise Vitamin D and extensively hydrolyzed protein having a degree of hydrolysis of at least about 20%, and wherein... | 08/28/2007 |
| 7223736 | Composition for the prevention and treatment of cachexia The present invention relates to methods and nutritional compositions for the prevention and treatment of cachexia and anorexia. The methods of the invention comprise administering a composition comprising effective amounts of ω-3 fatty acids such as alpha-linoleni... | 05/29/2007 |
| 7183266 | Dual induced viscosity fiber system and uses thereof The present invention relates generally to a method of blunting the postprandial glycemic response to a meal by feeding a dual induced viscosity fiber system. The first component of the induced viscosity fiber system is soluble fiber. The second component of the ind... | 02/27/2007 |
| 7090862 | Method of improving the antioxidant status of an infant The present invention relates generally to a method of improving the antioxidant status of an infant. More particularly, the present invention relates to a method of improving the antioxidant status of an infant by administering a mixture of natural tocopherols. The... | 08/15/2006 |
| 7090879 | Nutritional formula containing select carotenoid combinations Disclosed are nutritional formulas, including reconstitutable powders, comprising carbohydrate, protein and a lipid component containing a polyunsaturated fatty acid; and from about 0.25 to about 10 ppm, by weight of the total oil content of the infant formula, of a... | 08/15/2006 |
| 7070825 | Infant formula The present invention is directed to a new unit dose packaging for infant formula. The infant formula is manufactured as a tablet. One tablet will typically contain sufficient nutrients to produce a single serving of the formula (i.e. the amount of formula an averag... | 07/04/2006 |
| 7067498 | Polymer controlled induced viscosity fiber system and uses thereof The present invention relates generally to a method of blunting the postprandial glycemic response in a human by feeding an induced viscosity fiber system. The invention also relates to an induced viscosity fiber system and the liquid products that incorporate the i... | 06/27/2006 |
| 7033579 | Anhydrous antiperspirant and deodorant compositions containing solid vitamin B3 particulates and glycerin Disclosed are anhydrous antiperspirant and deodorant compositions that comprise from about 0.1% to about 30% by weight of an antiperspirant or deodorant active; from about 0.01% to about 20% by weight of a solid, water-soluble Vitamin B3 material; from about 0.1% to... | 04/25/2006 |
| 7026298 | Oral rehydration compositions The present invention is directed to a zinc supplemented ORS and its use in the treatment of diarrhea. ... | 04/11/2006 |
| 6906038 | Methods for alleviating mucositis The present invention is directed to a method for alleviating mucositis, sassociated with radiation and chemotherapy, via the administration of an oral rehydration solution. ... | 06/14/2005 |
| 6849268 | Method for improving bone mineralization The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced... | 02/01/2005 |
| 6810716 | Apparatus and method for analysis of headspace gases of a pouch Disclosed is a test container for the release and containment of headspace gases from pouches comprises a housing sealed with a lid and a pouch opening device. Determination of the concentration of a particular gas component is conducted by analyzing a background sa... | 11/02/2004 |
| 6811804 | Juice and soy protein beverage and uses thereof The present invention relates generally to a thin texture, ready-to-drink, shelf-stable refreshing juice/soy beverage. Other aspects of this invention relate to methods of providing phytochemicals from soy, fruit and vegetable juices to a health conscious population... | 11/02/2004 |
| 6811801 | Methods and compositions for brightening the color of thermally processed nutritionals In accordance with the present invention, it has been discovered that the addition of lutein compounds to thermally processed nutritionals brightens the nutritional resulting in a more appealing color. Thermally processed liquid and powder nutritionals typically pre... | 11/02/2004 |
| 6596767 | Infant formula and methods of improving infant stool patterns The invention is directed to an improved infant formula containing a lipid blend that softens the firmer stools associated with typical infant formula. A specific formula in accordance with the invention comprises carbohydrates, proteins, vitamins and min... | 07/22/2003 |
| 6403072 | Anhydrous antiperspirant and deodorant compositions containing a solid, water-soluble, skin active agent and glycerin Disclosed are anhydrous antiperspirant and deodorant compositions that comprise from about 0.1% to about 30% by weight of an antiperspirant or deodorant active; from about 0.1% to about 20% by weight of a water-soluble, skin active solid (e.g., solid, wat... | 06/11/2002 |
| 6403071 | Anhydrous antiperspirant and deodorant compositions containing solid d-pantothenate salts Disclosed are anhydrous antiperspirant and deodorant compositions comprising from about 0.1% to about 30% by weight of an underarm active (antiperspirant and/or deodorant active); from about 0.01% to about 10% by weight of a solid, water-soluble, d-pantot... | 06/11/2002 |
| 6399049 | Compositions containing solubilized antiperspirant active Disclosed are antiperspirant compositions which comprise from about 0.1% to about 50% by weight of solubilized antiperspirant active (e.g., aluminum containing materials or aluminum-zirconium containing materials), and from about 0.1% to about 99.9% by we... | 06/04/2002 |
| 6383476 | Anhydrous antiperspirant and deodorant compositions containing a solid, water-soluble, skin active agent Disclosed are anhydrous antiperspirant and deodorant compositions that comprise from about 0.1% to about 30% by weight of an antiperspirant or deodorant active; from about 0.1% to about 20% by weight of a water-soluble, skin active solid (e.g., solid, wat... | 05/07/2002 |
| 6344218 | Skin deodorizing and santizing compositions The present invention relates to aqueous compositions comprising an odor controlling agent and select sanitizing agents for deodorizing and sanitizing skin surfaces. Articles of manufacture and methods of deodorizing and sanitizing the skin using disclose... | 02/05/2002 |
| 6312678 | Cleansing compositions comprising water-soluble surfactant and water-insoluble oil Rinse-off liquid personal cleansing compositions comprise from about 1% to about 60% by weight of a water-soluble surfactant, and 0.5% or greater of a water-soluble oil selected from type (b) having the following formula: ##STR1## wherein R1 is... | 11/06/2001 |